Abstract
The adaptive immune system is tasked with defending the body against specific foreign invaders and does so via T and B cell receptors present on the surfaces of T and B lymphocytes. These receptors develop as a result of recombination of gene segments, allowing for a variety of possible receptors that can recognize a wide range of possible antigens. Due to the complexity of the mechanisms involved in the development of the adaptive immune response, there are several possible pharmacological targets that are useful for suppression of the immune system in the treatment of autoimmune diseases or immune cell cancers. Some of these targets include inhibition of activation or inhibition of pro-inflammatory signaling pathways. Conversely, the adaptive immune system can also be stimulated in an effort to better produce an immune attack towards infectious diseases and certain types of cancers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bao K, Reinhardt RL. The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. Cytokine. 2015;75(1):25–37.
Brinc D, Lazarus AH. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am Soc Hematol Educ Program. 2009:185–91.
Dubey AK, Handu SS, Dubey S, Sharma P, Sharma KK, Ahmed QM. Belimumab: first targeted biological treatment for systemic lupus erythematosus. J Pharmacol Pharmacother. 2011;2(4):317–9.
Durandy A, Kracker S. Immunoglobulin class-switch recombination deficiencies. Arthritis Res Ther. 2012;14(4):218.
Fernandez-Ramos AA, Marchetti-Laurent C, Poindessous V, Antonio S, Laurent-Puig P, Bortoli S, Loriot MA, Pallet N. 6-mercaptopurine promotes energetic failure in proliferating T cells. Oncotarget. 2017;8:43048–60.
Gaud G, Lesourne R, Love PE. Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol. 2018;18:485–97.
Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3S1):S28–36.
Gorentla BK, Zhong X-P. T cell receptor signal transduction in T lymphocytes. J Clin Cell Immunol. 2012;2012(Suppl 12):005.
Hammers CM, Stanley JR. Antibody phage display: technique and applications. J Invest Dermatol. 2014 Feb;134(2):e17.
Huynh Du F, Mills EA, Mao-Draayer Y. Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment. Auto Immun Highlights. 2017;8(1):12.
Kennedy BK, Lamming DW. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab. 2016;23(6):990–1003.
Kopecky O, Lukesova S. Genetic defects in common variable immunodeficiency. Int J Immunogenet. 2007;34(4):225–9.
Norman DJ. Mechanisms of action and overview of OKT3. Ther Drug Monit. 1995;17(6):615–20.
Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033–44.
Puig L. Brodalumab: the first anti-IL-17 receptor agent for psoriasis. Drugs Today (Barc). 2017;53(5):283–97.
Ramamoorthy S, Cidlowski JA. Corticosteroids-mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016 Feb;42(1):15–31.
Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591–619.
Tan LD, Bratt JM, Godor D, Louie S, Kenyon NJ. Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy. 2016;9:71–81.
Zwick MB, Shen J, Scott JK. Phage-displayed peptide libraries. Curr Opin Biotechnol. 1998;9(4):427–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Szollosi, D.E., Mathias, C.B., McAleer, J.P. (2020). Modulation of the Adaptive Immune System. In: Mathias, C., McAleer, J., Szollosi, D. (eds) Pharmacology of Immunotherapeutic Drugs. Springer, Cham. https://doi.org/10.1007/978-3-030-19922-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-19922-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19921-0
Online ISBN: 978-3-030-19922-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)